ArticleACS omega2025
Hypergraph Learning with Hyperedge Gating and Multiscale Topology Feature Learning for Predicting Disease-Related circRNAs.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As circular RNAs (circRNAs) play a crucial role in the onset and progression of diseases, identification of disease-related circRNAs can provide deep insights into the pathogenesis of complex diseases. Constructing graph learning-based models is a widely used advanced approach to infer the associations between circRNAs and diseases. The biological correlations among multiple circRNAs, diseases, and miRNAs are complex and diverse. However, existing methods cannot sufficiently represent and encode those correlations. In addition, each circRNA (disease) node has its specific semantic within a meta-path, which is often neglected by the previous methods. To address these limitations, we propose a circRNA-disease association prediction model, HSCDA, which can encode the biological correlations among multiple circRNAs and diseases, learn the semantics of meta-path neighbors, and integrate the multiscale topology structure within a heterogeneous network. First, we construct a hypergraph comprising circRNA and disease nodes to uncover the intricate biological correlations among multiple circRNA and disease nodes. The hypergraph has learnable hyperedges so that HSCDA can dynamically refine the hypergraph topology to reflect multiperspective correlations. Second, we propose hypergraph convolution with a hyperedge gating mechanism (HGHG). HGHG adaptively estimates the hyperedge importance by leveraging the contributions of circRNA, disease, and miRNA nodes contained within each hyperedge. Third, a semantic-enhanced graph convolutional network (SGCN) is proposed to integrate the diverse semantics between circRNA and disease nodes within each meta-path. SGCN is able to generate semantic representations for each circRNA and disease node, derived from integrating the semantic features of meta-path neighbors and the node features. Finally, a multiscale topology transformer (MST) is introduced to effectively learn the structural characteristics of nodes by analyzing their multiscale neighbor topologies in a heterogeneous network. MST can adaptively form topological features by integrating information across various scales and encoding the close relationships among them. Experimental results demonstrate that HSCDA outperforms six comparing methods in predicting circRNA-disease associations. Ablation studies further demonstrate the effectiveness of HGHG, SGCN, and MST, while case studies on three diseases highlight HSCDA's ability in discovering potential circRNA candidates related to the diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.